Brendan O'Connor cover image

"Obesity stigma is rising due to new weight-loss drugs" - Prof. Donal O'Shea

Brendan O'Connor

00:00

How much do patients pay and is public funding changing?

Donal details current costs for Ozempic and Mounjaro, limited public coverage, price strategies by companies, and potential HTA outcomes.

Play episode from 15:30
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app